AnaptysBio, Inc.
Hedge Funds Holdings
Last updated:
AnaptysBio, Inc.‘s stocks are currently a part of 128 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 29.73M shares of AnaptysBio, Inc.. Compared to the previous quarter, the number grew by 7.12% or 1.97M shares more. As for the holding position changes, 25% (32) of current hedge fund investors increased the number of shares held, 39.84% (51) of current holders sold a part of the shares held, and 17.19% (22) closed the holdings completely. 17 hedge funds are new holders of AnaptysBio, Inc. stock in Q1 2022, it is 13.28% of total holders.
Hedge funds holding AnaptysBio (Q2 2017 – Q1 2022)
| Q2 2017 | 53 |
|---|---|
| Q3 2017 | 71 |
| Q4 2017 | 116 |
| Q1 2018 | 134 |
| Q2 2018 | 123 |
| Q3 2018 | 130 |
| Q4 2018 | 120 |
| Q1 2019 | 127 |
| Q2 2019 | 125 |
| Q3 2019 | 118 |
| Q4 2019 | 117 |
| Q1 2020 | 112 |
| Q2 2020 | 119 |
| Q3 2020 | 127 |
| Q4 2020 | 133 |
| Q1 2021 | 119 |
| Q2 2021 | 119 |
| Q3 2021 | 124 |
| Q4 2021 | 134 |
| Q1 2022 | 128 |
Hedge funds changes in AnaptysBio positions (Q2 2017 – Q1 2022)
| Q2 2017 | 10 | 22 | 12 | 8 | 1 |
|---|---|---|---|---|---|
| Q3 2017 | 25 | 31 | 10 | 7 | -2 |
| Q4 2017 | 52 | 41 | 19 | 7 | -3 |
| Q1 2018 | 37 | 43 | 43 | 18 | -7 |
| Q2 2018 | 19 | 61 | 33 | 29 | -19 |
| Q3 2018 | 26 | 49 | 38 | 17 | 0 |
| Q4 2018 | 20 | 46 | 36 | 30 | -12 |
| Q1 2019 | 21 | 53 | 29 | 13 | 11 |
| Q2 2019 | 23 | 59 | 23 | 22 | -2 |
| Q3 2019 | 16 | 54 | 32 | 22 | -6 |
| Q4 2019 | 37 | 47 | 18 | 38 | -23 |
| Q1 2020 | 18 | 42 | 36 | 21 | -5 |
| Q2 2020 | 25 | 29 | 44 | 18 | 3 |
| Q3 2020 | 21 | 29 | 50 | 13 | 14 |
| Q4 2020 | 23 | 36 | 45 | 16 | 13 |
| Q1 2021 | 13 | 41 | 39 | 25 | 1 |
| Q2 2021 | 16 | 25 | 50 | 16 | 12 |
| Q3 2021 | 15 | 30 | 42 | 9 | 28 |
| Q4 2021 | 25 | 37 | 42 | 15 | 15 |
| Q1 2022 | 17 | 32 | 51 | 22 | 6 |
Hedge funds changes in AnaptysBio stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 0 | 0 |
|---|---|---|
| Q3 2017 | 0 | 0 |
| Q4 2017 | 20,430,000 | 14,156,000 |
| Q1 2018 | 40,677,000 | 54,113,000 |
| Q2 2018 | 6,742,000 | 15,838,000 |
| Q3 2018 | 88,809,000 | 37,689,000 |
| Q4 2018 | 11,653,000 | 7,736,000 |
| Q1 2019 | 16,450,000 | 13,254,000 |
| Q2 2019 | 5,515,000 | 11,054,000 |
| Q3 2019 | 20,323,000 | 18,555,000 |
| Q4 2019 | 7,835,000 | 11,478,000 |
| Q1 2020 | 2,439,000 | 3,517,000 |
| Q2 2020 | 574,000 | 3,512,000 |
| Q3 2020 | 25,000 | 1,280,000 |
| Q4 2020 | 4,602,000 | 1,666,000 |
| Q1 2021 | 7,657,080 | 7,927,000 |
| Q2 2021 | 1,431,000 | 2,107,000 |
| Q3 2021 | 673,000 | 300,000 |
| Q4 2021 | 1,508,000 | 0 |
| Q1 2022 | 362,000 | 0 |